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Results: Epidemiological investigations revealed that
anorectal diseases in Wuhan perianal SSI of the average
rate of NI was 32.98%. After statistical analysis, compared
with anorectal diseases perianal incision infection for the
patient’s hospital stay (t = 5.62, P< 0.01), the incision site
of microbial strains and the number of bacteria changes
(X2 = 22.94 and X2 = 60.29, P< 0.01), and other relevant
factors, it has signiﬁcance difference.
Conclusion: Through this survey, it was the ﬁrst time to
acquire the epidemiological data which was about perianal
SSI in anorectal diseases in Wuhan, it will provide the
scientiﬁc basis to prevent and control perianal SSI in
anorectal diseases.
Keywords: Anorectal Diseases; Nosocomial Infection (NI);
Perianal Surgical site infection (SSI); Epidemiology;
Prevalence/ Incidence
PP-079 One untypical case of normal temperature
during the eruption of adult measles
C.L. Liu, C.W. Wang, P. Zhou. Department of Infectious
Disease, General Hospital of Air Force, Beijing, 10036,
China
The patient, male, 28 years old, was a booking ofﬁce clerk at
the airport. He was hospitalized in the General Hospital of
Air Force at 8 p.m. on September 4, 2008 after his ﬁve-day
pyrexia, three-day cough, two-day diarrhea, and one-day
rash. The patient began to have a fever on August 30, and
his temperature had risen from 37.9ºC to 39.4ºC. He had got
a cough on September 1, and then had diarrhea water stool
6 7 times a day without the abdominal pain on September 2.
The pink rash appeared on his cheeks on the morning of
September 4, spreading gradually over the whole body.
The other symptoms included sore throat, dizziness, and
malaise, uncomplicated by photophobia, shedding tears,
stuffy nose, and running nose. The patient had neither
ever caught measles nor contacted with other measles
patients. Physical examination: T 36.3ºC; big or small pink
maculae spread over the body, ranging successively from
cheeks, trunk to limbs according to the intensity, and no
maculae on the center of hands and feet. The skin between
the maculae was normal, fading upon being pressed; The
throat appeared red, tonsils were swollen and not covered
with white patches, and Koplik’s spots were on the left
buccal mucosa;All of the lungs, heart, and abdomen were
normal. The patient had taken antifebrile im and po on
August 30 and 31, afterwards not taken any antifebrile
until 4 days before being hospitalized. His temperature
was 38.9ºC in emergency department, and fell to normal
in ward in two hours. Single medication: Banlangen 10g,
bid, po. Chemical examination: On September 5, blood
routine, WBC 6.1×109/L, N 76.1%; ALT 48U/L, AST 54U/L,
LDH 309U/L, GGT 184U/L; stool routine, WBC 2 3/HP, OB +;
measles antibody IgM +, rubella antibody IgM . Abdominal
ultrasonic: All of liver and gall bladder were normal. Next
day in ward, the eruption appeared on the centre of hands
and feet, meanwhile diarrhea stopped. On September 9,
ALT 64U/L, AST 32U/L; the rash disappeared completely,
followed by brown pigmentation without the desquamation.
The patient was discharged from hospital on September 10.
and came back to the outpatient service for a chemical
reexamination in half a month, all results of ALT, AST, GGT
returned to normal.
Born in the metropolitan city, the patient should have been
vaccinated, but he had not any records of immunization
because of the limits in those years.
This paper aims at emphasizing to discern the possibilities
of the untypical measles from the patient with normal
temperature during the eruption. The injury of liver
associated with measles could be fully recovered with the
convalescence.
PP-080 CpG-DNA encapsulated with peptide antigens
of P. vivax in microparticles enhances the
systemic and mucosal immune responses in
mice using intranasal mode of delivery: an
approach towards mucosal vaccine for malaria
A.A. Bhat1 *, R.K. Seth2, S. Kumar1, R. Ali1, S.K. Sharma3,
S. Biswas2, D.N. Rao1. 1Dept. of Biochemistry, All India
Institute of Medical Sciences, New Delhi; 2National
Institute of Malaria Research, New Delhi; 3National
Institute of Malaria Research, Rourkela, Orissa, India
Introduction: Due to drug resistance and limitation of
growing of P. vivax parasite in vitro for enough DNA/Protein,
we attempted an alternate synthetic peptide approach from
the deduced amino acid sequences of different antigens
of P. vivax constituting all the stages of the life cycle.
For producing efﬁcient and long lasting humoral immune
responses, PLGA microparticles were used as delivery
vehicles and CpG ODN as immunoadjuvants.
Objective: To study the mucosal and systemic immune
responses in mice with coentrapped peptide antigens and
CpG ODN in microparticles.
Methodology: P. vivax peptides viz, MSP 1#1, MSP 1#23, CSP,
AMA, and Pvs24 (TBA) possessing B and T cell epitopes were
synthesized using Fmoc chemistry. These peptide antigens
were then entrapped in microparticles along with CpG-ODN.
Outbred strains of mice were immunized using intranasal
route with different peptide formulations. Peptide speciﬁc
IgG, IgA and SIgA estimation was done by standardized ELISA
protocol.
Results and Conclusion: Presence of CpG (1826 or 2006)
in microparticles along with the peptide antigens showed
serum IgG titre of 51,200 204,800 maintained till 90 days
post immunization. The isotypic proﬁle of the serum IgG
revealed IgG2a/2b as the predominant isotypes, maintained
till 90 days post immunization. Peptide speciﬁc IgA titre
in sera ranged between 12,800 and 25,600 maintained
till 90 days post immunization and SIgA titre in washes
ranged between 800 and 25,600. Infected mosquitoes fed
with high titer Pvs24 (TBA) anti-sera showed signiniﬁcant
reduction in the oocyst count as revealed by membrane
feeding assay. This study shows CpG ODN to be a potent
mucosal adjuvant to induce immune responses against
peptide antigens administered by intranasal inhalation. This
is the ﬁrst reported study with mucosal vaccination for
malaria and also for these peptides.
PP-081 Cadaveric and living donor liver transplantation
for acute on chronic hepatic failure patients
caused by hepatitis B. A preliminary report of
90 cases
S.C. Lu, M.L. Wang, N. Li. Hepato-pancreato-biliary surgery
department and liver transplantation center, Beijing
Youan hospital, Capital Medical University, Beijing 100069,
China
Objective: To summarize the experience of cadaveric and
living donor liver transplantation for acute on chronic
hepatic failure patients caused by Hepatitis B.
Methods: The clinical and follow-up data of consecutive
90 cases (80 cadaveric donor Ltx and 10 LDLT) from June
2004 to January 2008 were analyzed retrospectively.
Results: All the 90 patients had high MELD score as well
as Child C liver function, and the mean MELD score is
30.9±6.5 (range from 25 to 40). Before receiving Liver
transplantation, they suffered from severe complications
including abnormal renal function 45.6% (41/90), hepatic
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encephalopathy 36.7% (33/90), lungs infection and
abdominal infection 17.8% (16/90), hepatorenal syndrome
23.3% (21/90), as well as alimentary tract hemorrhage
16.7% (15/90). 63 patients totally underwent plasma
pheresis, continuous hemoﬁltration and Molecular Absorbent
Recirculating System (MARS) therapy 76 sessions. HBV active
replication (HBVDNA positive) occurred in 78.9% of the
patients (71/90). 15 patients died within 30 days after
Ltx, and the perioperative mortality is 16.7%. Leading
post-Ltx complications were lungs infection 41.1% (37/90).
There were no primary liver nonfunction and blood vessel
complications in all the patients. Biliary complication
accounts for 12.2% (11/90).One-year survival is 76.1%
(54/71). Lamivudine combined HBIG were used to prevent
HBV recurrence, and there was no HBV graft reinfection and
hepatitis B recurrence during a mean 23-month follow up
period.
Conclusion: Acute on chronic hepatitis B patients
waiting for Ltx are generally with severe damaged liver
function, multiple-organ impairment and inner environment
derangement Therefore much should be done to improve
organ function so that better inner environment can be
obtained before Ltx. While during Surgery, attention should
be paid in the maintenance of coagulability and urine
output and in the shrinking of operation time. Attention
should also be paid to the intensive care of liver, lung
and kidney functions, the appropriate living graft volume,
the individual use of immunsuppresive agent and the
effective prophylaxis for acute lungs injury and secondary
infections post-operatively. With sufﬁcient efforts in all the
aspects listed above, acute on chronic hepatitis B patients
underwent Ltx could expect a satisfactory clinical outcome
and a better quality of life.
PP-082 Liver transplantation for the treatment of
hepatocellular carcinoma: A single center
report of 103 cases
S.C. Lu, J.S. Wu, M.L. Wang, W. Lai, N. Li. Department of
Hepatobiliary Surgery and liver transplant center, Beijing
Youan hospital, Capital Medical University, Beijing 100069,
China
Objective: To compare the long-term survivals of
orthotropic liver transplantation (OLT) in patient of HCC
within different selection criteria and analyze the risk
factors of tumor recurrence after liver transplantation.
Methods: OLT was performed on 103 patients with HCC at
Department of surgery of Beijing You-An hospital between
April 2004 and March 2008. The data were retrospectively
analyzed with regard to the response to OLT and survival.
The patients are divided into three group according to the
characteristics of tumor: group A (within Milan criteria),
group B (extra Milan criteria within UCSF criteria) and
group C (beyond UCSF criteria). Accumulative survival
rate and tumor-free Survivals were compared among three
groups.
Result: 1-, 2-, 3-year accumulative survival rate of 103
patients were 84.0%, 70.5% and 60.2%, which were 93.4%,
83.8%, 73.2% in group A (n = 50), 93.3%, 79.4%, 66.2%
in group B (n = 17) and 67.0%, 45.5%, 34.1% in group C
(n = 36) respectively. There is no difference in long-term
survival rate between group A and group B (P = 0.631),
while signiﬁcant difference between group A and group C
(P = 0.001) or group B and group C (P = 0.045).
Conclusion: HCC fulﬁlling Milan criteria is best indicated
for liver transplantation, and satisﬁed outcomes can be
achieved for the HCC recipients exceeding Milan criteria
but within UCSF criteria as well. Prognostic risk factors are
tumor staging and microvascular invasion of tumor.
PP-083 Baseline ALT and HBVDNA levels predict long
term therapeutic outcomes in adefovir (ADV)
treated Chinese HBeAg(+) chronic hepatitis B
(CHB) patients
M.D. Zeng1, Y.M. Mao1, G.B. Yao2, H. Ren3, Y.G. Chen4,
D.Z. Xu5, Y.M. Chen6. 1Renji Hospital, Shanghai, 2Jing-An
Qu Central Hospital, Shanghai; 32nd Hospital of Chongqing
Medical University, Chongqing; 41st Hospital of Zhejiang
University, Hangzhou; 5Ditan Hospital, Beijng; 6Sun Yet-San
3rd Hospital, Guangzhou, China
Background: Previous results have demonstrated that
HBeAg loss and seroconversion rates on ADV therapy were
signiﬁcantly correlated with baseline ALT levels. We present
predictors of long-term treatment outcomes, based on
both baseline ALT and HBV levels to help optimise patient
management.
Methods: Retrospective multivariate analyses assessed
the effects in a sub-group of study subjects with
baseline ALT >2×ULN and HBVDNA 108 copies/mL on-
treatment outcomes at Week 208.
Results: Subjects with baseline ALT >2×ULN and HBVDNA
108 copies/mL (n = 44) showed superior outcomes
compared to other study subjects with the proportion
achieving HBVDNA 300 copies/mL (68.18% vs. 52.02%,
P= 0.041), HBeAg loss (59.09% vs. 40.87%, P= 0.020), and
HBeAg seroconversion (38.64% vs. 23.80%, P= 0.031).
In subjects with baseline ALT >2×ULN and HBVDNA 108
copies/mL, and detextable HBVDNA at Week 208 ADV-
associated mutations were seen in 3.92% compared to 10.4%
in other subjects.
Conclusion: High baseline ALT and low baseline HBVDNA
were predictive of 4-years treatment outcomes in HBeAg-
Positive patients. Long-term outcomes were signiﬁcantly
better in HBeAg-Positive patients with baseline ALT >2×ULN
and HBVDNA 108 copies/mL.
PP-084 Early virologic response predicts therapeutic
outcomes in adefovir-treated HBeAg-positive
chronic hepatitis B (CHB) patients
J.L. Hou1, Y.Z. Wang2, X.Q. Zhou3, J.Q. Niu4, Y.M. Wang5,
H. Wang6, Y.M. Mao7. 1NanFang Hospital, Guangzhou;
2Jinan Infectious Disease Hospital, Jinan; 3Ruijin Hospital,
Shanghai; 41st Hospital of Jilin University, Changchun;
5Xinan Hospital, Chongqing; 6People’s Hospital, Beijing;
7Renji Hospital, Shanghai, China
Background: Long-term antiviral therapy is the most
common approach in the treatment of CHB. Prediction
of long-term treatment outcomes based on early virologic
response may help optimize patient management.
Methods: 240 HBeAg positive CHB subjects received ADV
(adefovir dipivoxil 10mg) treatment for 208 weeks. The
effects of HBVDNA levels at Week 40 and outcomes at Week
208 were assessed by multivariate analyses.
Results: Subjects were grouped by HBVDNA at week 40:
105 and >105 copies/mL (table).
HBV DNA at Week 40
105 >105 P value
DNA undetectablea 72.87% 12.50% <0.001
HBeAg loss 55.04% 10.94% <0.001
HBeAg seroconversion 31.01% 4.69% <0.001
ALT normalization 85.27% 59.38% <0.001
ADV Mutation 10.08% 21.88% 0.026
a
300 copies/mL.
Conclusion: Low HBVDNA at Week 40 was predictive
of 4-year treatment outcomes in HBeAg-Positive chronic
